最新ニュース Apollomics (NASDAQ:APLM) 株価情報

Apollomics

Apollomics Inc is an innovative clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company lead programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other advanced tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.

Apollomics Inc. - Class A Ordinary Shares

Apollomics Inc

Ecolab (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ECL#NYSE">ECL</a>) has outperformed the market over the past 20 years by 2.39% on an annualized basis producing an average annual return of 10.8%. Currently, Ecolab has a market capitalization of $69.64 billion. 
Buying $1000 In ECL: If an investor had bought $1000 of ECL stock 20 years ago, it would be worth $7,652.15 today based on a price of $245.94 for ECL at the time of writing.
<h3>Ecolab's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739231111_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

News

Trading Ideas

$1000 Invested In This Stock 20 Years Ago Would Be Worth This Much Today

Needham analyst Scott Berg maintains Monday.Com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>) with a Buy and raises the price target from $350 to $400.

Price Target

Analyst Ratings

MNDY

Needham Maintains Buy on Monday.Com, Raises Price Target to $400

Needham analyst Quinn Bolton maintains ON Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) with a Buy and lowers the price target from $66 to $57.

Needham Maintains Buy on ON Semiconductor, Lowers Price Target to $57

Jones Lang LaSalle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JLL#NYSE">JLL</a>) has outperformed the market over the past 20 years by 1.53% on an annualized basis producing an average annual return of 9.94%. Currently, Jones Lang LaSalle has a market capitalization of $13.26 billion. 
Buying $100 In JLL: If an investor had bought $100 of JLL stock 20 years ago, it would be worth $650.19 today based on a price of $279.45 for JLL at the time of writing.
<h3>Jones Lang LaSalle's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739230218_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Jones Lang LaSalle 20 Years Ago Would Be Worth This Much Today

Marvell Technology, Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) stock has surged about 350% in the last five years as the <a target="_blank" href="https://www.benzinga.com/topic/artificial-intelligence" rel="noreferrer noopener">artificial intelligence frenzy</a> has triggered demand for hardware and infrastructure.
The company supplies data infrastructure semiconductor solutions, spanning the data center core to the network edge. It is a fabless semiconductor supplier of high-performance standard and semi-custom products with core strengths in developing and scaling complex System-on-a-Chip architectures, integrating analog, mixed-signal, and digital signal processing functionality.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/02/43570917/cloudflares-ai-expansion-and-enterprise-growth-set-the-stage-for-big-gains-analysts" rel="noreferrer noopener">Buy Cloudflare Or Sell? Analysts Vary Over Sales Acceleration And Business Momentum</a>
Its solutions empower the data economy and enable the data center, enterprise networking, carrier infrastructure, consumer, and automotive/industrial end markets.
Aswath Damodaran of the Stern School of Business at New York University flagged how computer chips have become part of every consumer good in the last four decades, from <a target="_blank" href="https://aswathdamodaran.substack.com/p/ais-winners-losers-and-wannabes-valuing" rel="noreferrer noopener">appliances to automobiles</a>.
He noted that semiconductor chip customers have also shifted from personal computers to smartphones, with demand emerging from automobile, crypto, and gaming companies in the last decade.
Apple Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) became the first <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/19/10/14589580/apple-microsoft-battle-for-position-as-worlds-most-valuable-company-by-market-cap" rel="noreferrer noopener">trillion-dollar company</a> in 2018 as its iPhones gained traction. It is currently worth over $3.4 trillion. Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) hit the trillion-dollar market cap in 2024 and is currently worth ~ $ $3.2 trillion, backed by its AI processors.
Damodaran also said that data processing has emerged as a demand driver. He highlighted the potential upside of the automobile business, backed by automated driving and other enhancements.
Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) also reached a trillion-dollar valuation, supported by Elon Musk&#8217;s EVs and autonomous driving technology.
Reportedly, a third of the ten global companies worth <a target="_blank" href="https://www.benzinga.com/media/25/01/42762874/broadcom-thrives-with-114-stock-surge-in-ai-boom-while-intel-faces-steep-decline" rel="noreferrer noopener">over $1 trillion</a> came from the chip industry, as 2024 proved immensely beneficial for the U.S. semiconductor sector.
For Marvell, China accounted for 42%- 44% of its revenue between fiscal <a target="_blank" href="https://app.quotemedia.com/data/downloadFiling?webmasterId=101533&amp;ref=318157157&amp;type=HTML&amp;symbol=MRVL&amp;cdn=36dc57774e0f888a3d7612adedcf3e12&amp;companyName=Marvell+Technology+Inc.&amp;formType=10-K&amp;dateFiled=2024-03-13" rel="noreferrer noopener">2022 and 2024</a>, while the U.S. generated 11%- 14%.
The company reported a 7% decline in fiscal 2024 revenue after a 33% growth in fiscal 2023 due to a decrease in sales in the majority of its end markets, including data center, enterprise networking, consumer, and carrier infrastructure, partially offset by growth in the automotive/industrial end market.
The decline coincides with the slowdown in Chinese demand, which impacted the company&#8217;s gross margin, which remained at 42% in fiscal 2024 versus 50% in 2023.
Semiconductor companies have adopted organic growth strategies (e.g., investing in research and development, product innovation, and operational efficiency improvements) or inorganic growth strategies (via acquisitions, mergers, or strategic partnerships) to expand their market share.
R&amp;D consumed 32%- 34% of Marvell&#8217;s revenue between fiscal 2022 and 2024, compared to bigger rival Broadcom Inc&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>) 15%- 18%. In absolute terms, Broadcom&#8217;s <a target="_blank" href="https://investors.broadcom.com/financial-information/annual-reports" rel="noreferrer noopener">R&amp;D stood at</a> $9.3 billion in fiscal 2024 on revenue of $51.6 billion versus Marvell&#8217;s R&amp;D at $1.9 billion on revenue of $5.5 billion.
In relative terms, Marvell&#8217;s R&amp;D margin is comparable to that of British chip designer Arm Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>). Arm&#8217;s fiscal 2024 <a target="_blank" href="https://investors.arm.com/financials/sec-filings" rel="noreferrer noopener">R&amp;D margin stood</a> at 61% on revenue of $3.23 billion. Still, Marvell posted a gross margin of above 40%, which is testimony to its pricing power or moat.
Marvell stock surged over 57% in the last 12 months, <a target="_blank" href="https://www.spglobal.com/spdji/en/indices/equity/sp-global-semiconductor-index/#overview" rel="noreferrer noopener">topping</a> S&amp;P Global Semiconductor Index&#8217;s 11%. Marvell commands an EV/EBITDA multiple of 262.5x versus Arm&#8217;s 283.1x and Broadcom&#8217;s 47.9x.
Marvell&#8217;s dividend yield is 0.20%, compared to 1.00% for Broadcom or 0.5% for Micron Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MU#NASDAQ">MU</a>).
Marvell&#8217;s inorganic growth strategies include mergers and acquisitions. On October 5, 2021, Marvell completed the acquisition of Innovium, Inc., a provider of networking solutions for cloud and edge data centers, for $1.0 billion. On April 20, 2021, Marvell completed the acquisition of Inphi, a provider of <a target="_blank" href="https://www.benzinga.com/m-a/20/10/18135863/marvell-confirms-merger-with-chipmaker-inphi-to-create-40b-entity" rel="noreferrer noopener">high-speed data movement</a> enabled by optical interconnects, for $9.9 billion.&nbsp;
Marvell&#8217;s operating cash flow, net of capital expenditures, helped it generate $1.02 billion in free cash flow as of February 3, 2024, compared to $1.07 billion in 2023 and $632 million in 2022.
Excess cash flows above capex help a company pay dividends and/or buyback shares, thereby adding to shareholder value. A company may also use the surplus funds for acquisitions and debt repayment to fuel growth.
Marvell&#8217;s positive AI catalysts for 2025: OpenAI,&nbsp;SoftBank Corp (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SFTBF#OTC">SFTBF</a>) (OTC:<a class="ticker" href="https://www.benzinga.com/stock/SFTBY#OTC">SFTBY</a>), and&nbsp;Oracle Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) launched a&nbsp;<a target="_blank" href="https://www.benzinga.com/25/01/43127416/anthropic-gains-big-with-google-backing-aiming-for-60-billion-valuation-and-surging-ai-revenue" rel="noreferrer noopener">$500 billion joint venture</a>, Stargate, to build AI infrastructure in the U.S.
Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) committed $80 billion for AI-driven data centers. Alphabet Inc&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google&nbsp;earmarked over $1 billion for its OpenAI rival Anthropic.
BofA Securities Vivek Arya <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/25/02/43570410/broadcoms-trillion-dollar-run-analyst-expects-asic-to-take-10-15-market-share-backed-by-ai-compute-demand" rel="noreferrer noopener">expressed optimism over</a> AI infrastructure providers like Marvell, which are backed by AI compute/networking demand. He expects Application-Specific Integrated Circuit (ASIC) vendors like Marvell and Broadcom (which hit the trillion dollars market cap in 2024) to bag over a 10%-15% share of the overall accelerator market as Nvidia GPUs dominate with their 80%+ share.
JPMorgan&#8217;s&nbsp;Harlan Sur noted that Marvell is <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/25/01/42859614/jpmorgan-sees-marvells-ai-revenue-surge-with-2-billion-run-rate-in-networking-by-2025" rel="noreferrer noopener">well-positioned to</a> significantly exceed its previous AI target of $2.5 billion in calendar 2025. This is backed by AI optical/copper networking products and two AI ASIC programs for&nbsp;Amazon.Com Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), Amazon Web Services, and&nbsp;Google.
Marvell is a holding in 200 US-traded&nbsp;ETFs. Investors can gain exposure to the stock through Vanguard Total Stock Market ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VTI#NYSE">VTI</a>)
and Invesco QQQ Trust, Series 1 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>).
MRVL&nbsp;Price Action: Marvell Technology stock closed up by 1.97% to $112.50 on Monday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/02/43570022/fortinets-firewall-refresh-and-enterprise-deals-drive-growth-analysts-highlight-upsell-potential" target="_blank" rel="noreferrer noopener">Fortinet&#8217;s Firewall Refresh and Enterprise Deals Drive Growth, Analysts Highlight Upsell Potential</a></li>
</ul>
Photo via Shutterstock

Tech

AAPL

AMZN

AVGO

GOOG

GOOGL

MRVL

MSFT

NVDA

ORCL

SFTBF

SFTBY

TSLA

Behind Marvell Tech's Multi-Fold Growth: R&D, Acquisitions And AI Infrastructure

Equities

Buybacks

Management

Insider Trades

Markets

Elliott Management's Activist Campaigns: The Special Situations Report

GITS

Global Interactive Regains Compliance With Nasdaq's Minimum Bid Price Requirement

Modine Manufacturing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MOD#NYSE">MOD</a>) has outperformed the market over the past 15 years by 4.83% on an annualized basis producing an average annual return of 16.88%. Currently, Modine Manufacturing has a market capitalization of $5.19 billion. 
Buying $100 In MOD: If an investor had bought $100 of MOD stock 15 years ago, it would be worth $1,037.50 today based on a price of $98.81 for MOD at the time of writing.
<h3>Modine Manufacturing's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739228450_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$100 Invested In Modine Manufacturing 15 Years Ago Would Be Worth This Much Today

Earnings

SEED

Origin Agritech FY24 EPS $0.46 Down From $1.17 YoY, Sales $16.18M Up From $13.00M YoY

Motorola Solns (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MSI#NYSE">MSI</a>) has outperformed the market over the past 20 years by 27.45% on an annualized basis producing an average annual return of 35.86%. Currently, Motorola Solns has a market capitalization of $80.51 billion. 
Buying $1000 In MSI: If an investor had bought $1000 of MSI stock 20 years ago, it would be worth $476,990.10 today based on a price of $481.76 for MSI at the time of writing.
<h3>Motorola Solns's Performance Over Last 20 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739227510_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In Motorola Solns 20 Years Ago Would Be Worth Today

Rosenblatt analyst Barton Crockett maintains Lions Gate Enter (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LGF#NYSE">LGF</a>) with a Buy and maintains $13 price target.

Lions Gate Entertainment Corporation Class B Non-Voting Shares

LGF/B

Rosenblatt Maintains Buy on Lions Gate Enter, Maintains $13 Price Target

FreeCast's streaming platform will be available to users of the Company's mobile device portfolio. The new integration will give Foxx Development's users immediate access to FreeCast's entertainment hub, consolidating hundreds of streaming services into a single user-friendly interface.

FOXX

Foxx Development Enters Strategic Distribution Agreement With FreeCast

Coca-Cola Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>) has a history of beating analyst estimates in recent quarters and looks to keep the streak alive with its fourth-quarter financial results before <a href="https://www.benzinga.com/earnings">the market opens Tuesday</a>.
Earnings Estimates: Analysts expect Coca-Cola to report fourth-quarter earnings per share of 52 cents. That&#8217;s up from 49 cents in last year's fourth quarter, according to data<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent021025&amp;t=be2bearmibe3na1"> from Benzinga Pro.</a>
The company has beaten analyst estimates for earnings per share in three straight quarters and eight of the last 10 quarters overall. The other two quarters the company didn't beat estimates, the results were in-line with analysts.
Analysts expect Coca-Cola to report fourth-quarter revenue of $10.68 billion, down from $10.85 billion in last year's fourth quarter.
The Atlanta-based company has beaten analyst estimates for revenue in 15 straight quarters, according to Benzinga Pro data.
Read Also: <a href="https://www.benzinga.com/trading-ideas/technicals/25/02/43605038/coca-cola-stock-is-bubbling-higher-can-q4-earnings-keep-the-fizz-going">Coca-Cola Stock Is Bubbling Higher: Can Q4 Earnings Keep The Fizz Going?</a>
What Analysts Are Saying: Piper Sandler analyst Michael Lavery said Coca-Cola has attractive and sustainable growth drivers. In an investor note last month, he highlighted the North America and Latin America regions for seeing strong growth that can be sustainable over the long term.
Lavery initiated coverage on the stock with an Overweight rating and a $74 price target, which was later revised down to $73 later in January.
The analyst said the North America and Latin America regions still have a large percentage of their populations that do not drink commercial beverages, offering an expansion opportunity.
Rising incomes in emerging markets along with population growth could be long-term drivers for "sustainable volume and pricing gains," Lavery said.
Here are other recent<a href="https://www.benzinga.com/quote/KO/analyst-ratings"> analyst ratings on Coca-Cola</a> and their price targets.
<ul>
<li>RBC Capital: Reiterated Outperform rating, raised price target from $68 to $69</li>
<li>Jefferies: Upgraded from Hold to Buy, raised price target from $69 to $75</li>
<li>JPMorgan: Maintained Overweight rating, lowered price target from $75 to $70</li>
<li>Barclays: Maintained Overweight rating, lowered price target from $73 to $66</li>
</ul>
Key Items to Watch: Coca-Cola's earnings report comes after rival PepsiCo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>) recently<a href="https://www.benzinga.com/25/02/43460249/pepsicos-q4-sales-miss-estimates-on-downcast-performance-in-north-america-stock-dives"> reported fourth-quarter financial results. </a>Pepsi shares fell after the report with the company missing analyst estimates.
While Pepsi competes in both the beverage and food markets, the company's North American PepsiCo division is most comparable with the beverage unit of Coca-Cola in North America. This segment saw flat revenue in the quarter for Pepsi.
Coca-Cola's report could include a look at inflation, consumer spending habits and more on how higher prices for several grocery items are impacting spending on beverages.
The beverage giant is a key market indicator as a member of the Dow Jones Industrial Average, although the company's lower share price makes the stock the 28th largest weighting of 30 stocks.
The company's earnings report will also be closely watched by legendary investor Warren Buffett and Berkshire Hathaway Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>)(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>).
Berkshire Hathaway owns 400 million Coca-Cola shares. The stock is one of the largest holdings of the legendary investor's conglomerate.
Investors and analysts, and maybe Buffett, will be interested to hear if Coca-Cola provides an update on 2025 guidance. <a href="https://www.benzinga.com/news/earnings/24/10/41486650/coca-cola-q3-earnings-eps-beat-pricing-growth-offset-by-volume-decline-sees-10-q4-organic-revenue-g">The company expects</a> adjusted net revenue and earnings per share to have a low single-digit and mid-single-digit currency headwind, respectively.
Price Action: Coca-Cola stock was up 1.1% to $64.55 on Monday versus a 52-week trading range of $57.93 to $73.53. Coca-Cola stock is up 7.5% over the last year.
Shares of rival Pepsi trade at $143.73 versus a 52-week trading range of $141.51 to $183.39. Pepsi stock is down 15.8% over the last year.
Both Coca-Cola and Pepsi shares have underperformed the S&amp;P 500. The SPDR S&amp;P 500 ETF Trust is up 20.7% over the past year.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/02/43591420/how-to-earn-500-a-month-from-coca-cola-stock-ahead-of-q4-earnings">How To Earn $500 A Month From Coca-Cola Stock Ahead Of Q4 Earnings</a></li>
</ul>
Image: Shutterstock

Previews

Coca-Cola Q4 Earnings Preview: Can Warren Buffett Favorite Keep Streak Of Revenue Beats Alive?

Rosenblatt analyst Barton Crockett maintains Walt Disney (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DIS#NYSE">DIS</a>) with a Buy and maintains $135 price target.

Rosenblatt Maintains Buy on Walt Disney, Maintains $135 Price Target

Verisk Analytics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRSK#NASDAQ">VRSK</a>) has outperformed the market over the past 15 years by 4.86% on an annualized basis producing an average annual return of 16.9%. Currently, Verisk Analytics has a market capitalization of $41.52 billion. 
Buying $1000 In VRSK: If an investor had bought $1000 of VRSK stock 15 years ago, it would be worth $10,407.08 today based on a price of $294.00 for VRSK at the time of writing.
<h3>Verisk Analytics's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739226617_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

VRSK

Here's How Much $1000 Invested In Verisk Analytics 15 Years Ago Would Be Worth Today

Mild winter weather for the first two months of the quarter contributed to a softer quarter than had been assumed in the company's original forecast.&nbsp;

Guidance

Compass Minerals Cuts 2025 Salt Segment Revenue Outlook From $940M - $1.04B To $900M - $1B

Rosenblatt analyst Hans Mosesmann maintains Lattice Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSCC#NASDAQ">LSCC</a>) with a Buy and maintains $85 price target.

LSCC

Rosenblatt Maintains Buy on Lattice Semiconductor, Maintains $85 Price Target

Compass Minerals Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CMP#NYSE">CMP</a>) reported quarterly losses of $(0.55) per share which missed the analyst consensus estimate of $0.15 by 466.67 percent. The company reported quarterly sales of $307.20 million which beat the analyst consensus estimate of $294.00 million by 4.49 percent. This is a 10.10 percent decrease over sales of $341.70 million the same period last year.

Earnings Beats

Earnings Misses

Compass Minerals Intl Q1 2025 Adj EPS $(0.55) Misses $0.15 Estimate, Sales $307.20M Beat $294.00M Estimate

MARA

MARA Holding Postpones Special Meeting Of Stockholders To February 19, 2025

RCUS

Arcus Biosciences Plans To Present New Data from Casdatifan Via Oral Presentation At 2025 ASCO GU Symposium

Apollomics (APLM) will affect a 1-for-100 reverse share split of its class A ordinary shares, par value $0.0001 per share, which will become effect...

Apollomics announces approval, date for 1-for-100 reverse share split

19:50 EST Apollomics (APLM) Inc trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving breaking ...

Apollomics Inc trading halted, news pending

These are the upcoming stock splits for the week of November 25 to November 29, based on&nbsp;TipRanks' Stock Splits Calendar. A&nbsp;stock split&n...

Upcoming Stock Splits This Week (November 25 to November 29) – Stay Invested

13:36 EST Apollomics (APLM) Inc trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financial new...

Apollomics Inc trading resumes

13:31 EST Apollomics (APLM) Inc trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, market-movi...

Apollomics Inc trading halted, volatility trading pause

Apollomics regains compliance with Nasdaq's minimum bid price requirement

Apollomics (APLM) announced that on December 10 it received a notification from The Nasdaq Stock Market LLC stating that the Company has regained c...

Apollomics regains compliance with Nasdaq minimum bid rule

09:55 EST Apollomics (APLM) Inc trading resumes Published first on TheFly – the ultimate source for real-time, market-moving breaking financial new...

09:45 EST Apollomics (APLM) Inc trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, market-movi...

Apollomics (APLM) announced the results from its Phase 3 bridging trial of uproleselan in China in patients with relapsed or refractory acute myelo...

Apollomics announces results from Phase 3 bridging trial of uproleselan

APLM

CETX

GPUS

Press Releases

Apollomics to Present at the Canaccord Genuity 44th Annual Growth Conference

Apollomics Announces Positive Preliminary Data of Vebreltinib in Patients with Non-CNS MET Fusion Solid Tumors from its Phase 2 SPARTA Trial

Biotech Sees Massive Buying Pressure Following Phase 2 Preliminary Data

Apollomics Reports First Half 2024 Financial Results and Highlights Vebreltinib Clinical Progress

Apollomics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Apollomics Presents Vebreltinib Data in Patients with Non-Small Cell Lung Cancer with METex14 Skipping Mutations at European Society for Medical Oncology (ESMO) Congress 2024

Spotlight on Undervalued Nasdaq Stocks: HCWB, CRDL, NIVF, SINT, APLM – A Must-Watch This Week!

Apollomics' Announces Shareholder Approval and Effective Date for 1-for-100 Reverse Share Split

General

Apollomics Regains Compliance with Nasdaq's Minimum Bid Price Requirement

Health Care

Apollomics Announces Top-line Results for Phase 3 Bridging Trial of Uproleselan in China in Patients with Relapsed or Refractory Acute Myeloid Leukemia

Comments

Apollomics

ニュース

最新ニュース Apollomics (NASDAQ:APLM) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル